2-chloro-4-[cyclohexylmethyl-[(3S)-1-(1,3-thiazole-4-carbonyl)pyrrolidin-3-yl]amino]benzonitrile
C22H25ClN4OS — CID 143704619
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-chloro-4-[cyclohexylmethyl-[(3S)-1-(1,3-thiazole-4-carbonyl)pyrrolidin-3-yl]amino]benzonitrile
2-chloro-4-[cyclohexylmethyl-[(3S)-1-(1,3-thiazole-4-carbonyl)pyrrolidin-3-yl]amino]benzonitrile (PubChem CID 143704619) has the molecular formula C22H25ClN4OS and a molecular weight of 428.99 g/mol. Its IUPAC name is 2-chloro-4-[cyclohexylmethyl-[(3S)-1-(1,3-thiazole-4-carbonyl)pyrrolidin-3-yl]amino]benzonitrile.
Molecular Properties
| Compound Name | 2-chloro-4-[cyclohexylmethyl-[(3S)-1-(1,3-thiazole-4-carbonyl)pyrrolidin-3-yl]amino]benzonitrile |
|---|---|
| PubChem CID | 143704619 |
| Molecular Formula | C22H25ClN4OS |
| Molecular Weight | 428.99 g/mol |
| Exact Mass | 428.14 |
| IUPAC Name | 2-chloro-4-[cyclohexylmethyl-[(3S)-1-(1,3-thiazole-4-carbonyl)pyrrolidin-3-yl]amino]benzonitrile |
| SMILES | N#Cc1ccc(N(CC2CCCCC2)[C@H]2CCN(C(=O)c3cscn3)C2)cc1Cl |
| InChI | InChI=1S/C22H25ClN4OS/c23-20-10-18(7-6-17(20)11-24)27(12-16-4-2-1-3-5-16)19-8-9-26(13-19)22(28)21-14-29-15-25-21/h6-7,10,14-16,19H,1-5,8-9,12-13H2/t19-/m0/s1 |
| InChIKey | ILTUKKZVALTMPK-IBGZPJMESA-N |
| XLogP | 4.97 |
| TPSA | 60.23 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 428.99 |
| LogP ≤ 5 | 4.97 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143704619 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.